Fallout

Heard there was bleeding occurring - what happened?

 

The DoucheBags who bought Dendrite for SEVEN HUNDRED FIFTY MILLION DOLLARS did not have the foresight to understand this product type was in the tail of it's product life cycle. This, coupled with the Pharma consolidations, R&D pipeline failures and patent cliffs do not make a Pharma CRM vendor so 'special' anymore. Customers are looking at Veeva as the leader in this narrow sector. Growth is not possible for now and unless they build some new compelling product, this shoppe will continue to just cut costs to survive. Doesnt look too promising.